| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/26/2004 | EP1420644A1 Substituted propargylamines |
| 05/26/2004 | EP1117661B1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 05/26/2004 | EP1117652B1 Tan-1057 derivatives |
| 05/26/2004 | EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | EP0968194B1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 05/26/2004 | EP0945440B1 Aminopyrazole derivatives |
| 05/26/2004 | EP0839138B1 Process for producing n-substituted 3-hydroxypyrazoles |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1500086A Aminopiperidine derivatives |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1500081A Thiohydantonins and use thereof for treating diabetes |
| 05/26/2004 | CN1500080A 稠合杂环化合物 Fused heterocyclic compounds |
| 05/26/2004 | CN1500078A Aryl oxime-piperazines useful as CCR5 antagonists |
| 05/26/2004 | CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 05/26/2004 | CN1151151C Method for producing f-methoxy-quinoline carboxylic acids |
| 05/26/2004 | CN1151148C Farnesy transferase inhibitors having pyrrole structure and process for preparation thereof |
| 05/26/2004 | CN1151147C Indole derivatives as 5-HT receptor antagonist |
| 05/26/2004 | CN1151138C Triazole antifungal agent |
| 05/26/2004 | CN1151136C Fused pyridazine compound |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1151132C Process for production of 2-pyridylpyridine derivatives |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/26/2004 | CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |
| 05/25/2004 | US6740757 Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740661 Farnesyl protein transferase inhibitors |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740654 Inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders, or disorders involving the inappropriate growth or migration of cells. |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/25/2004 | CA2302058C A process for preparing 5-methoxy-4-methyl-2,4-dihydro-3h-1,2,4-triazol-3-one |
| 05/25/2004 | CA2115170C Imidazolyl-alkenoic acids |
| 05/21/2004 | WO2004042351A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041818A1 Anti-infective agents |
| 05/21/2004 | WO2004041816A1 Azacyclic compounds as orexin receptor antagonist |
| 05/21/2004 | WO2004041809A2 Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands |
| 05/21/2004 | WO2004041808A1 4-imidazol-1-ylmethyl-pyrimidine derivatives_as ligands for gabaa receptors |
| 05/21/2004 | WO2004041807A1 Novel compounds |
| 05/21/2004 | WO2004041806A2 Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists |
| 05/21/2004 | WO2004041795A1 Novel inhibitors of dipeptidyl peptidase iv |
| 05/21/2004 | WO2004041791A1 N-aryl acetyl cyclic amine derivatives as orexin antagonists |
| 05/21/2004 | WO2004041789A1 Compositions useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | WO2004041788A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 05/21/2004 | WO2004041784A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041782A1 Indoles useful in the treatment of androgen-receptor related diseases |
| 05/21/2004 | WO2004041777A2 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041776A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 05/21/2004 | WO2004041755A2 Quinazolinone compounds as calcilytics |
| 05/21/2004 | WO2004041282A1 Receptor regulator |
| 05/21/2004 | WO2004041279A1 Gamma-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041264A1 2-oxo-ethanesulfonamide derivates |
| 05/21/2004 | WO2004041258A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | WO2004041209A2 Transcription factor modulating compounds and methods of use thereof |
| 05/21/2004 | WO2004041163A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004014860A3 Fused heterocyclic compounds as peptidase inhibitors |
| 05/21/2004 | WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 05/21/2004 | WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003086605A3 Functionalized ionic liquids, and methods of use thereof |
| 05/21/2004 | CA2506772A1 Compositions useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | CA2504805A1 Receptor regulator |
| 05/21/2004 | CA2503844A1 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2503720A1 Gamma-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2503716A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | CA2503713A1 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2502302A1 Quinazolinone compounds as calcilytics |
| 05/21/2004 | CA2502178A1 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/21/2004 | CA2500800A1 Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists |
| 05/21/2004 | CA2495708A1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors |
| 05/21/2004 | CA2484936A1 Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands |
| 05/20/2004 | US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 05/20/2004 | US20040097732 Peptide deformylase inhibitors |
| 05/20/2004 | US20040097731 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1and tnf |
| 05/20/2004 | US20040097730 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 05/20/2004 | US20040097729 Substituted pyridine herbicides |
| 05/20/2004 | US20040097725 Charge transport compositions and electronic devices made with such compositions |
| 05/20/2004 | US20040097578 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 05/20/2004 | US20040097574 For therapy of inflammatory, allergic, or proliferative processes |
| 05/20/2004 | US20040097571 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 05/20/2004 | US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 05/20/2004 | US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents |
| 05/20/2004 | US20040097561 Benzamides and related inhibitors of factor Xa |
| 05/20/2004 | US20040097560 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 05/20/2004 | US20040097559 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 05/20/2004 | US20040097550 For therapy of thrombosis, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, tumours, tumour diseases and/or tumour metastases |
| 05/20/2004 | US20040097546 For therapy of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
| 05/20/2004 | US20040097545 Quinolinone derivatives |
| 05/20/2004 | US20040097532 3-Substituted oxindole beta 3 agonists |
| 05/20/2004 | US20040097531 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia |
| 05/20/2004 | US20040097530 Novel heteroaryl derivatives and their use as medicaments |
| 05/20/2004 | US20040097525 Novel Compounds |
| 05/20/2004 | US20040097518 For use in therapy and prophylaxis |
| 05/20/2004 | US20040097515 Having reduced cardiac toxicity; for therapy of infections |
| 05/20/2004 | US20040097513 Novel non-imidazole compounds |
| 05/20/2004 | US20040097508 Novel heterocyclically substituted amides, their preparation and use |